StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

Stock analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a research note issued on Friday. The firm set a “hold” rating on the stock.

China Pharma Stock Performance

China Pharma stock opened at $0.37 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.88 and a quick ratio of 0.33. The company’s 50-day moving average price is $0.40 and its two-hundred day moving average price is $0.50. China Pharma has a 52 week low of $0.32 and a 52 week high of $2.70.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.